| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/03/2012 | US8088825 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/03/2012 | US8088823 Tuberculosis treatment using pleuromutilin derivatives |
| 01/03/2012 | US8088754 Anti-proliferative compounds, compositions, and methods of use thereof |
| 01/03/2012 | US8088729 Anti-viral griffithsin compounds, compositions and methods of use |
| 01/03/2012 | US8088415 Core-and-shell dosage form or unit in which the core contains API and in which the shell substantially governs the release such as by controlling diffusion of API through the shell. The shell may comprise a release-blocking polymer, and particles |
| 01/03/2012 | US8088393 Swine influenza hemagglutinin variants |
| 01/03/2012 | US8088388 Complexing; water in oil emulsion; immunostimulant |
| 01/03/2012 | US8088377 Human monoclonal antibodies against CD30 |
| 01/03/2012 | US8088368 Antiviral compounds |
| 01/03/2012 | CA2660917C Process for producing benzoxazine derivative and production intermediate thereof |
| 01/03/2012 | CA2622639C Hiv integrase inhibitors |
| 01/03/2012 | CA2547775C In ovo vaccination of campylobacter in avian species |
| 01/03/2012 | CA2542102C Indole antiviral compositions and methods |
| 01/03/2012 | CA2514558C Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 01/03/2012 | CA2508932C Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same |
| 01/03/2012 | CA2505183C Substituted quinazolines as antiviral agents, especially against cytomegaloviruses |
| 01/03/2012 | CA2504846C Antiviral nucleoside derivatives |
| 01/03/2012 | CA2496902C Medicament for activating the phagocytic capacity of macrophages |
| 01/03/2012 | CA2490200C 2' and 3'-nucleoside prodrugs for treating flaviviridae infections |
| 01/03/2012 | CA2489128C 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
| 01/03/2012 | CA2488565C Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 01/03/2012 | CA2465117C Lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 01/03/2012 | CA2463134C Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 01/03/2012 | CA2457863C Process for preparing glycopeptide phosphonate derivatives |
| 01/03/2012 | CA2453243C Treatment of nail infections with no |
| 01/03/2012 | CA2428728C Combination antiperspirant and antimicrobial compositions |
| 01/03/2012 | CA2425202C Immunoreactive peptide ctl epitopes of human cytomegalovirus pp150 |
| 01/03/2012 | CA2420618C Percarboxylated polysaccharides, and a process for their preparation |
| 01/03/2012 | CA2379539C Feline calicivirus genes and vaccines, in particular recombinant vaccines |
| 01/03/2012 | CA2366433C Staphylococcus antigen and vaccine |
| 01/03/2012 | CA2348658C Vaccine preparations containing attenuated toxin |
| 01/03/2012 | CA2334960C Combination of tgf-.beta. inhibition and immune stimulation to treat hyperproliferative diseases |
| 01/03/2012 | CA2284000C Hydrophilic binary systems for the administration of cyclosporine |
| 01/03/2012 | CA2261346C Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
| 01/03/2012 | CA2260855C Polynucleotide vaccine formula in particular against bovine respiratory pathology |
| 01/03/2012 | CA2236591C Continuous low-dose cytokine infusion therapy |
| 01/03/2012 | CA2226973C Modulators of the function of fas receptors and other proteins |
| 01/03/2012 | CA2222889C Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 12/30/2011 | CA2744562A1 Non-alcohol bioactive essential oil mouth rinses |
| 12/29/2011 | WO2011163628A2 Dengue virus (dv) polypeptide sequences, t cell epitopes and methods and uses thereof |
| 12/29/2011 | WO2011163610A2 Antimicrobial agents |
| 12/29/2011 | WO2011163533A2 One step removal of selected molecules from body fluid and tissue |
| 12/29/2011 | WO2011163321A2 Composition and method of treating lipid encapsulated virus infections |
| 12/29/2011 | WO2011162733A1 Antibacterial and/or antifungal component having the property of binding specifically to bacteria and/or fungi |
| 12/29/2011 | WO2011161653A1 Combinations of meningococcal factor h binding proteins |
| 12/29/2011 | WO2011161644A1 Treatment of hepatitis c virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent |
| 12/29/2011 | WO2011161491A1 Methods and pharmaceutical compositions for the treatment of respiratory tract infections |
| 12/29/2011 | WO2011161244A1 Homodimeric protein constructs |
| 12/29/2011 | WO2011160684A1 Use of uleine for the prevention and/or the treatment of infectious diseases |
| 12/29/2011 | WO2011160563A1 Novel porcine interferon and use thereof |
| 12/29/2011 | WO2011160425A1 Preparing method of allicin injection and low temperature continuous stirring ultrafiltration device thereof |
| 12/29/2011 | WO2011160252A1 Organic acid salts of penehyclidine optical isomer |
| 12/29/2011 | WO2011160191A1 Compound for the treatment of enteroviruses |
| 12/29/2011 | WO2011160170A1 Stimulating immune response |
| 12/29/2011 | WO2011134667A3 Selected plant extract hydrolysates, and antibacterial agent containing the same |
| 12/29/2011 | WO2011123645A3 Nucleoside phosphoramidates |
| 12/29/2011 | WO2011103458A3 Compositions and methods for using and identifying antimicrobial agents |
| 12/29/2011 | WO2011100508A3 Methods and compositions related to glycoprotein-immunoglobulin fusions |
| 12/29/2011 | WO2011099812A3 Composition for preventing or treating rotavirus infection containing licorice extract |
| 12/29/2011 | WO2011090345A3 Novel antibiotic composition comprising flufenamic acid as an active ingredient |
| 12/29/2011 | WO2011090307A3 Sirna having antiviral activity against both enterovirus 70 and coxsackievirus a24, and pharmaceutical composition for treating and preventing acute hemorrhagic conjunctivitis containing same |
| 12/29/2011 | WO2011088474A3 Sulindac and sulindac derivatives and their uses related to infection |
| 12/29/2011 | WO2010142030A8 Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens |
| 12/29/2011 | US20110319805 Topical composition for treating the skin |
| 12/29/2011 | US20110319496 Process for the preparation of ajoene |
| 12/29/2011 | US20110319490 Methods and compositions for the treatment of irritable bowel syndrome |
| 12/29/2011 | US20110319489 Enhanced stability peracid compositions |
| 12/29/2011 | US20110319485 Composition Having Anti-Helicobacter Pylori Activity And Its Application To Inhibit Helicobacter Pylori |
| 12/29/2011 | US20110319482 Novel treatments |
| 12/29/2011 | US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf |
| 12/29/2011 | US20110319455 Antifungal Treatment |
| 12/29/2011 | US20110319450 Benzimidazole compound crystal |
| 12/29/2011 | US20110319431 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 12/29/2011 | US20110319424 Naphthyridin-2(1h) -one compounds useful as antibacterials |
| 12/29/2011 | US20110319420 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor |
| 12/29/2011 | US20110319410 Pyrazine derivatives and use as pi3k inhibitors |
| 12/29/2011 | US20110319398 Inhibition of yops translocation |
| 12/29/2011 | US20110319381 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof |
| 12/29/2011 | US20110319364 Foaming alcohol compositions with selected dimethicone surfactants |
| 12/29/2011 | US20110319361 Boron-containing small molecules |
| 12/29/2011 | US20110319323 Pharmaceutical composition and method of use to improve organ function |
| 12/29/2011 | US20110319321 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof |
| 12/29/2011 | US20110319319 Antimicrobial kinocidin compositions and methods of use |
| 12/29/2011 | US20110319318 Covalent milk protein/isothiocyanate complexes |
| 12/29/2011 | US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1 |
| 12/29/2011 | US20110319267 Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers |
| 12/29/2011 | US20110318439 Plant extracts from acronychia species and their use |
| 12/29/2011 | US20110318438 Pharmacologically effective composition of herbs for treatment on symptoms of influenza and colds |
| 12/29/2011 | US20110318421 Surface functionalized ceramic nanoparticles |
| 12/29/2011 | US20110318416 Bioresorbable polymer matrices and methods of making and using the same |
| 12/29/2011 | US20110318414 Regenerative tissue grafts and methods of making same |
| 12/29/2011 | US20110318407 Inactivated dengue virus vaccine with aluminium-free adjuvant |
| 12/29/2011 | US20110318406 Lecithin carrier vesicles and methods of making the same |
| 12/29/2011 | US20110318403 Preparation and Use of Pouteria Lucuma Extract |
| 12/29/2011 | US20110318401 Treatment of leg ulcers using placenta derived collagen biofabric |
| 12/29/2011 | US20110318394 Multi-linked star-shaped polymers and synthetic methods therfor |
| 12/29/2011 | US20110318393 Substituted Pyrazole Compounds |
| 12/29/2011 | US20110318388 S1P Receptors Modulators and Their Use Thereof |
| 12/29/2011 | US20110318383 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 12/29/2011 | US20110318382 Immunomodulatory agents and methods of use |